Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
3/23/23 Sanofi (SNY) Dupixent for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only Subscribers Only
3/22/23 Biogen (BIIB) Tofersen for Amyotrophic Lateral Sclerosis (ALS) Subscribers Only Subscribers Only Subscribers Only
3/22/23 89bio (ETNB) BIO89-100 for Non-Alcoholic Steatohepatitis (NASH) Subscribers Only Subscribers Only Subscribers Only
3/21/23 Swedish Orphan Biovitrum (SOBI) SEL-212 for Gout Subscribers Only Subscribers Only Subscribers Only
3/21/23 Altimmune (ALT) Pemvidutide for Obesity Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
03/23/23 Subscribers Only Subscribers Only Trial Announcement - Initiation
03/24/23 Subscribers Only Subscribers Only Trial Data - Updated Results
03/27/23 Subscribers Only Subscribers Only Trial Data - Updated Results
03/25/23 - 03/28/23 Subscribers Only Subscribers Only Trial Data - Updated Results
03/28/23 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Back to the top Back to the top